There are no trials of BENICAR HCT demonstrating reductions in cardiovascular possibility in sufferers with hypertension, but at least one particular drug pharmacologically comparable to olmesartan medoxomil has shown these Rewards, and hydrochlorothiazide shown reduction of cardiovascular threa